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309 Delayed development in newly diagnosed infants with CF: the
importance of a broad based physiotherapy program
I. Eisenstadt1, T. Cohen1, D. Shoseyov1, E. Kerem1. 1CF Center, Hadassah
Medical Center Mount Scopus, Jerusalem, Israel
Background: Without neonatal screening programs for CF, infants with severe
respiratory involvement, FTT due to malabsorption and delayed neurological de-
velopment with hypotonia may be diagnosed late with CF. These infants display a
developmental delay until their nutritional and respiratory parameters improve.
Objective: To evaluate if physiotherapy, in addition to standard CF care will
improve developmental milestones and respiratory function.
Methods: Chest physiotherapy and neuro-developmental therapy according to Bo-
bath’s method, evaluation by AIMS scoring, high fat high caloric diets, intravenous
and inhaled antibiotic therapies
Results: Two infants, ages 18 months and 7 months respectively, with CF with
severe FTT and severe lung disease were treated. Both suffered from severe
hypotonia, developmental delay and were dependent on supplemental oxygen for an
extended period resulting in difﬁculties reaching developmental milestones. Under
treatment, the 1st child showed impressive progress at all levels, including decreased
oxygen support and weight gain. He could not sit by himself; crawl or transfer
between positions (neurodevelopment score (NDS) of a 5−6 months old infant).
At age 3.5 years he walks by himself on a wide base, transfers between positions
with hands support, plays and talks almost normally for his age (NDS of 2−3
year toddler). The developmental progress of the 2nd child was slow. He died
unexpectedly at home at age 15 months.
Conclusions: A broad based physiotherapy program will substantially improve
the reaching of developmental milestones in addition to the respiratory condition.
Greater attention must be given to the possibility of developmental delay in infants
with severe FTT who are diagnosed late with CF.
310* A proactive approach pays off in screened infants with CF
K.M. Sharp1, J.D. Wilkinson1. 1CF Unit, RHSC Yorkhill, Glasgow, United
Kingdom
Background: CF patients demonstrate lung inﬂammation early in life (Harm 2006).
In 2003 neonatal screening for CF was introduced in Scotland. This programme
ensures early diagnosis of CF. At RHSC Glasgow we advocate early intervention
with respiratory care to try to delay the onset of irreversible lung damage. Our
current physiotherapy modalities of choice are Positive Expiratory Pressure therapy
(PEP) and Assisted Autogenic Drainage (AAD). We abandoned Postural Drainage
and Percussion (PD/Perc) in 2005 as our primary aim is to ensure adequate airﬂow
through all generations of airways, preventing micro-atelectasis. We report results
of a retrospective audit of respiratory exacerbation admission rates within the ﬁrst
year of life in CF infants diagnosed by neonatal screening comparing the modalities
PD/Perc and PEP/AAD.
Methods: Since February 2003 there have been 32 infants diagnosed with CF in
our Region through neonatal screening. For the purpose of this audit we excluded
those who were complicated by abdominal surgery due to meconium ileus.
Prior to the change in physiotherapy modality 18 patients received daily PD/Perc.
From 2005 a further 14 patients received daily PEP/AAD. Admission rates for
respiratory exacerbation were observed in both groups.
Results: The total number of admissions for respiratory exacerbations in the
PD/Perc group was 30 compared to the PEP/AAD group where the total number
of admissions was 10. The mean number of admissions for the group receiving
PD/Perc was 1.667 (SD 2.029). The mean number of admissions with PEP/AAD
was 0.71 (SD 1.326).
Discussion: Our results suggest that changing the physiotherapy approach had a
positive inﬂuence on the number of admissions for exacerbation during the ﬁrst
year of life in screened CF infants.
311 Current practice in prescription, assessment and use of oxygen
therapy in cystic ﬁbrosis – a national UK survey
H.M. Douglass1, H. Potter1, N.A. Jarad1. 1Adult CF Centre, Bristol Royal
Inﬁrmary, Bristol, United Kingdom
Background and Aims: Oxygen supplementation therapy has been a standard
of care for CF individuals with advanced lung disease despite the current little
information on its use and prescription. The aim of this survey is to examine the
current practices in UK CF units for prescribing oxygen therapy.
Methods: We sent a questionnaire to lead respiratory/CF consultants caring for
CF patients in the UK. Items asked were, indications, prescribing guidelines and
current practices.
Results: Of the 160 questionnaires sent, 84 replies were received, 68% were from
paediatric units, 26% adult and 6% cared for both age groups (accounting for
approximately 4463 CF patients).
As anticipated, adult centres provided oxygen to a greater proportion of their
patients compared to paediatric units (5.4% and 1.9% respectively). The commonest
indications were hypoxia, breathlessness and terminal care.
The commonest outcome measures used for prescribing Long term oxygen therapy
(LTOT) were overnight oximetry and oxygen saturation. Educational support and
psychological assessment was considered by 69% and 56% of respondents’ units
respectively.
Almost all units were not inﬂuenced by cost of prescribing any form of Oxygen
therapy. 90% of respondent units did not believe that LTOT prolonged survival.
The commonest indications for prescribing Short burst oxygen therapy (SBO) and
Ambulatory oxygen (AO) were decreased exercise tolerance due to breathlessness
(70%) and hypoxia (61%).
Conclusions: Many CF units in the UK provide Oxygen therapy according to
clinical need and appear to be un-inhibited by cost. The units show some common
practices and themes surrounding oxygen usage among CF patients although there
still appears a lack of consensus, highlighting a need for further research and
standards.
312 An audit of the importance of nose clips for spirometry in CF
L. Boyle1, F. Kerr1, A. Dunn1, J. Rendall1, S. Elborn1. 1Regional Adult CF
Centre, Belfast City Hospital, Belfast, United Kingdom
Background: Although ATS guidelines recommend wearing nose clips during
spirometry, currently not all of our patients are agreeable to using nose clips during
spirometry.
Aim: To assess if there was a difference in spirometry performed with and without
nose clips.
Methods: 10 adults with CF from the Regional Adult CF Centre performed two
sets of spirometry 20 minutes apart. Each set consisted of three forced expiratory
maneuvers, one with and one without nose clips in a randomised order.
Data Analysis: The mean difference (MD), standard deviation (SD) and limits of
agreement were measured to assess the level of agreement between spirometry
results with and without nose clips.
Results: 10 subjects (9F:1M), with a mean (SD) age of 21.4 (4.89) yrs, completed
the study. There appears to be no signiﬁcant difference in spirometry results
performed with nose clips compared to spirometry performed without nose clips
(Table 1).
Conclusion: Although these results need to be veriﬁed in a much larger longitudinal
study this preliminary data suggests that not wearing nose clips does not affect
spirometry results.
Table 1
Difference, with nose-clips − without nose-clips
Mean SD Limits of agreement
FEV1 (L) 0.01 0.14 0.28 to 0.29
FEV1 (%) 0.20 4.21 −8.22 to 8.62
FVC (L) 0.64 0.25 0.14 to 1.14
FVC (%) 1.50 6.20 −10.91 to 13.91
PEF (L) −7.30 27.17 −61.65 to 47.05
PEF (%) −1.20 6.11 −13.41 to 11.01
FEF (L) −0.13 0.42 −0.98 to 0.72
FEF (%) −3.00 10.40 −23.81 to 17.81
